Date & Time: September 13th, 2022 | 10AM PT (1PM ET)
Location: Online
Presenters: Dr David Kisor, Dr Robin Everts, Amy Berk MSN, RN

Presented in partnership with GenXys

In this webinar leading industry experts Amy Berk, Director of Population Health at Microsoft, Dr. David Kisor, Director of the Master of Science in Pharmacogenomics Program at Manchester University, and Dr. Robin Everts, Senior Manager of Global Pharmacogenetics & Clinical Genetics at Agena Bioscience^®, will discuss the importance of the infrastructure that is needed for a successful pharmacogenetics initiative built for scalability, geographic reach, and regulatory oversight.

This exciting event will be hosted by GenXys’ Chief Medical Officer, Dr. Bernard Esquivel, and will outline key details necessary for the successful clinical application of pharmacogenetics globally. It is a must-see event for leaders in the industry looking to pave the way and accelerate their knowledge of PGx. Together, we will discuss the crucial elements of how PGx data gets generated for a clinician in a purposeful way and the part that infrastructure plays as the cornerstone to creating a successful pharmacogenetics program.